HEMATOLOGIC COMPLICATIONS OF RHEUMATIC DISEASE THERAPIES

Authors
GEORGE CS LICHTIN AE
Citation
Cs. George et Ae. Lichtin, HEMATOLOGIC COMPLICATIONS OF RHEUMATIC DISEASE THERAPIES, Rheumatic diseases clinics of North America, 23(2), 1997, pp. 425
Citations number
82
Categorie Soggetti
Rheumatology
Journal title
Rheumatic diseases clinics of North America → ACNP
ISSN journal
0889857X
Volume
23
Issue
2
Year of publication
1997
Database
ISI
SICI code
0889-857X(1997)23:2<425:HCORDT>2.0.ZU;2-P
Abstract
Rheumatic disease therapies have expanded to include many cytotoxic an d immunosuppressive agents in addition to corticosteroids and nonstero idal anti-inflammatory drugs. The use of more aggressive therapeutic i nterventions may expose patients to potential Life-threatening toxicit ies. This article reviews the potential cytopenias and malignant hemat ologic neoplasms associated with the use of some of these therapies. T he use of recombinant growth factors is also discussed.